Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

  • This share is currently suspended. It was suspended at a price of 0.89
  • There is currently no data for RBGP

Convex Capital Update

5 Mar 2021 07:00

RNS Number : 2491R
RBG Holdings PLC
05 March 2021
 

5 March 2021

 

RBG Holdings plc

(the "Group")

 

Convex Capital Update

 

RBG Holdings plc (AIM: RBGP), the professional services group, is pleased to announce a further update on the progress at Convex Capital Limited ("Convex Capital"), the Group's specialist sell-side corporate finance boutique.

 

Convex Capital has continued to convert its strong pipeline into completed transactions. Further to the update on 8 February 2021, Convex Capital has concluded another deal, earning a fee of £1.5 million. This brings the total number of completed transactions to four since 1 January 2021, resulting in a total fee income year to date of £2.6 million.

 

This represents a notable improvement in successful conversion, having completed only two deals, which generated total revenue of £1.5 million in 2020 because of the disruption caused by the pandemic. After working to pivot its sector focus, which resulted in a successful rebuild of its transaction pipeline over the last six months, Convex Capital is currently working on a further eight transactions which have the potential to complete in the short to medium term. The deal pipeline continues to be strong with a number of other deals across various sectors at earlier stages.

 

Nicola Foulston, CEO, RBG Holdings plc, said: "After a difficult year, the team at Convex Capital, led by CEO Mike Driver, worked hard to develop a new, stronger pipeline of M&A transactions. We can see the fruits of those efforts with four deals already completed this year and more to come. We expect to see an increase in M&A activity this year because of the market conditions, and Convex Capital is well placed to capitalise."

 

Enquiries:

RBG Holdings plc

Nicola Foulston, CEO

 

 Via SEC Newgate

 

N+1 Singer (Nomad and Broker)

Shaun Dobson / Alex Bond (Corporate Finance)

Tom Salvesen (Corporate Broking)

Tel: +44 (0)20 7496 3000

SEC Newgate (for media enquiries)

Robin Tozer/Tom Carnegie

Tel: +44 (0)7540 106366 rbg@secnewgate.co.uk

 

About RBG Holdings plc

RBG Holdings plc is a professional services group, which includes one of the UK's pioneering law firms, Rosenblatt Limited ("RBL" or the "Firm"), which is a leader in dispute resolution.

 

RBL provides a range of legal services to its diversified client base, which includes companies, banks, entrepreneurs, and individuals. Complementing this is the Firm's increasingly international footprint, advising on complex cross-jurisdictional matters. RBL's practice areas include banking & finance, competition & regulatory, corporate, dispute resolution, employment, financial crime, financial services, insolvency & financial restructuring IP/technology/media, real estate, serious & general crime, tax resolution and white-collar crime.

 

The Group also provides litigation finance in selected cases through a separate arm, LionFish Litigation Finance (UK) Limited ("LionFish"). LionFish finances litigation matters being run by other solicitors in return for a significant return on the outcome of those cases. As such, the Group has two types of litigation investments - RBL's own client matters, and litigation matters run by third-party solicitors. LionFish is positioned to be a unique, alternative provider to the traditional litigation funders.

 

The Group also owns Convex Capital Limited ("Convex Capital"), a specialist sell-side corporate finance boutique, based in Manchester. Convex Capital is entirely focussed on helping companies, particularly owner-managed and entrepreneurial businesses, realise their value through sales to large corporates. Convex Capital identifies and proactively targets firms that it believes represent attractive acquisition opportunities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZZGGFNDKGMZM
Date   Source Headline
26th Jul 20234:13 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSSale of LionFish Litigation Finance Limited
27th Jun 20237:00 amRNSDirectorate Change
22nd Jun 202311:11 amRNSResult of AGM & Directorate Change
23rd May 20239:07 amRNSNotice of AGM and Dividend
17th May 20233:28 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSResults for the year ended 31 Dec 2022
18th Apr 20237:00 amRNSNotice of Investor Presentation
3rd Mar 202312:44 pmRNSCorrection: Board Changes and Notice of Results
3rd Mar 202312:18 pmRNSBoard Changes and Notice of Results
31st Jan 20237:00 amRNSBoard Changes & Pre-Close Trading Update
3rd Jan 20237:00 amRNSDirectorate Changes
12th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20229:05 amRNSSecond Price Monitoring Extn
5th Dec 20229:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSTrading & Dividend Update
13th Sep 20227:00 amRNSUnaudited Interim Results
15th Aug 20227:00 amRNSInvestor Presentation
19th Jul 202211:26 amRNSProgressive publishes new research
18th Jul 20227:00 amRNSPre-Close Trading Update
23rd Jun 202212:03 pmRNSResult of AGM
7th Jun 20225:20 pmRNSLimited Employee Share Sale to Satisfy Demand
30th May 20224:55 pmRNSAnnual Report and Accounts and Notice of AGM
1st Apr 20229:33 amRNSCorrection: Results for year ended 31 Dec 2021
1st Apr 20227:01 amRNSAudited results - year ended 31 December 2021
1st Apr 20227:00 amRNSExecutive Incentive Plan
30th Mar 20221:29 pmRNSRevised Notice of Results & Investor Presentation
25th Mar 20222:09 pmRNSRevised Notice of Results
15th Feb 20227:00 amRNS£20 million litigation investment arrangement
27th Jan 20227:00 amRNSPre-Close Trading & Dividend Update
21st Jan 20227:00 amRNSInvestor Presentation
11th Jan 20227:00 amRNSPurchase of Shares by Directors of Convex
2nd Dec 20217:00 amRNSPurchase of Shares by Directors of Convex
29th Sep 20217:00 amRNSPurchase of Shares by Directors of Convex
15th Sep 20217:00 amRNSUnaudited Interim Results
13th Sep 20218:00 amRNSPurchase of Shares by Directors of Convex
2nd Sep 20217:00 amRNSIntegration Update
16th Jul 20217:00 amRNSPre-Close Trading & Dividend Update
5th Jul 20218:03 amRNSPurchase of Shares by Directors of Convex
17th Jun 20212:39 pmRNSBoard Changes
17th Jun 20212:33 pmRNSResult of AGM
28th May 20215:18 pmRNSCompletion of acquisition
25th May 20213:56 pmRNSNotice of AGM and Shareholder Q&A
11th May 20216:09 pmRNSAnnual Report and Accounts and AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.